Wellgistics Health, Inc. (WGRX)

Wellgistics Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-39.2	-6.86	-2.9	-0.02
Depreciation & Amortization	1.94	1.11	-	-
Stock-Based Compensation	28.85	1.08	-	-
Provision & Write-off of Bad Debts	0.17	0.09	-	-
Change in Accounts Receivable	-0.22	-0.04	-	-
Change in Inventory	-0.29	-0.07	-	-
Change in Accounts Payable	0.91	-0.88	1.03	0.02
Change in Other Net Operating Assets	5.23	4.34	1.51	-
Operating Cash Flow	-2.6	-1.22	-0.35	-
Cash Acquisitions	0.93	0.93	-	-
Sale (Purchase) of Intangibles	-0.65	-0.38	-	-
Other Investing Activities	-0.09	-0.09	-	-
Investing Cash Flow	0.2	0.47	-	-
Short-Term Debt Issued	-	0.76	-	-
Long-Term Debt Issued	-	1.31	0.35	-
Total Debt Issued	2.91	2.07	0.35	-
Short-Term Debt Repaid	-	-0.14	-	-
Total Debt Repaid	-0.51	-0.14	-	-
Net Debt Issued (Repaid)	2.39	1.94	0.35	-
Issuance of Common Stock	4	0.01	0	-
Other Financing Activities	-1.76	-0.16	-	-
Financing Cash Flow	4.63	1.78	0.35	-
Net Cash Flow	2.22	1.03	0	-
Cash Interest Paid	0.95	0.33	-	-
Levered Free Cash Flow	18.23	6.37	-	-
Unlevered Free Cash Flow	19.43	6.89	-	-
Change in Net Working Capital	-12.67	-8.91	-	-

Updated Dec 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q